FindTrial
Sign In

To See The Effect Of T-Shape Incision Mention In Ayurveda Followed By Cauterisation In The Managemnet Of Fistula-In-Ano.

An Open Label Single Arm Clinical Study To Revalidate Sushrutokta Langalaka Incision Followed By Agnikarma In Vataja Bhagandara - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075405
Enrollment
30
Registered
2024-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K605- Anorectal fistula

Interventions

None listed

Sponsors

DR ROHIT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects with Vataja Bhagandara with multiple opening around the anal canal. 2.Subjects with Recurrent Anal Fistula.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Diagnosed cases of High Anal Fistula connected to PNS, Rectovesical Fistula, Rectovaginal Fistula and Rectoscrotal Fistula. 3.Fistula caused secondary to Tuberculosis, Crohn’s disease, Ulcerative colitis, CA of Rectum,HIV and Hepatitis B. 4.Uncontrolled DM and other Systemic disorders.

Design outcomes

Primary

MeasureTime frame
The prime aim of the treatment is to eradicate the tract and drain all collections from the site of infection while preserving anal continence and minimize the re-occurrence.Timepoint: 1st, 7th, 14th, 21st and 28th day—

Secondary

MeasureTime frame
To Revalidate the Langalaka incision in Vataja Bhagandara. Timepoint: 1st, 7th, 14th, 21st and 28th day—

Countries

India

Contacts

Public ContactDR SIDDAYYA ARADHYAMATH

Rajiv Gandhi University Of Health Sciences,Banglore.

drsiddesharadhyamath@gmail.com9449972788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026